- 1
Sophie Tezenas du Montcel
1
Documents
Publications
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trialThe Lancet Neurology, 2022, 21, pp.225 - 233. ⟨10.1016/s1474-4422(21)00457-9⟩
Article dans une revue
hal-03852287v1
|